Carl Zeiss Meditec AG (CZMWF)
USD 64.88
(-0.29%)
USD 64.88
(-0.29%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 145.09 Million EUR | 20.74% |
| 2022 | 120.17 Million EUR | 5.57% |
| 2021 | 113.83 Million EUR | 79.54% |
| 2020 | 63.4 Million EUR | 81.93% |
| 2019 | 34.85 Million EUR | 735.33% |
| 2018 | 4.17 Million EUR | 120.86% |
| 2017 | 1.88 Million EUR | 599.63% |
| 2016 | 270 Thousand EUR | 133.05% |
| 2015 | -817 Thousand EUR | -132.37% |
| 2014 | 2.52 Million EUR | -68.55% |
| 2013 | 8.02 Million EUR | -62.47% |
| 2012 | 21.38 Million EUR | 111.62% |
| 2011 | -183.94 Million EUR | 37.71% |
| 2010 | -295.32 Million EUR | -62.48% |
| 2009 | -181.76 Million EUR | -3.35% |
| 2008 | -175.87 Million EUR | -1.42% |
| 2007 | -173.4 Million EUR | -5917.07% |
| 2006 | 2.98 Million EUR | 105.96% |
| 2005 | -50 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 10.6 Million EUR | -92.69% |
| 2024 Q2 | 126.66 Million EUR | 1094.88% |
| 2024 Q3 | 15.33 Million EUR | -87.89% |
| 2023 Q2 | 198.94 Million EUR | 2473.94% |
| 2023 Q1 | 7.72 Million EUR | -93.57% |
| 2023 Q4 | 145.09 Million EUR | 1073.53% |
| 2023 Q3 | 12.36 Million EUR | -93.79% |
| 2023 FY | 145.09 Million EUR | 20.74% |
| 2022 Q3 | 8.4 Million EUR | -92.48% |
| 2022 Q4 | 120.17 Million EUR | 1330.47% |
| 2022 FY | 120.17 Million EUR | 5.57% |
| 2022 Q1 | 7.43 Million EUR | -93.46% |
| 2022 Q2 | 111.64 Million EUR | 1400.83% |
| 2021 Q2 | 111.58 Million EUR | 1699.15% |
| 2021 Q3 | 8.31 Million EUR | -92.55% |
| 2021 Q4 | 113.83 Million EUR | 1268.98% |
| 2021 Q1 | 6.2 Million EUR | -90.22% |
| 2021 FY | 113.83 Million EUR | 79.54% |
| 2020 Q4 | 63.4 Million EUR | 324.19% |
| 2020 FY | 63.4 Million EUR | 81.93% |
| 2020 Q1 | 22.63 Million EUR | -35.04% |
| 2020 Q2 | 38.56 Million EUR | 70.36% |
| 2020 Q3 | 14.94 Million EUR | -61.25% |
| 2019 Q4 | 34.85 Million EUR | 234.13% |
| 2019 Q1 | 7.84 Million EUR | 87.99% |
| 2019 Q2 | 49.98 Million EUR | 537.35% |
| 2019 Q3 | 10.43 Million EUR | -79.13% |
| 2019 FY | 34.85 Million EUR | 735.33% |
| 2018 FY | 4.17 Million EUR | 120.86% |
| 2018 Q4 | 4.17 Million EUR | -77.41% |
| 2018 Q3 | 18.46 Million EUR | 1400.63% |
| 2018 Q2 | -1.42 Million EUR | -117.08% |
| 2018 Q1 | 8.31 Million EUR | 340.18% |
| 2017 Q1 | 8.71 Million EUR | 3125.93% |
| 2017 Q4 | 1.88 Million EUR | -88.4% |
| 2017 Q2 | -1.42 Million EUR | -116.39% |
| 2017 FY | 1.88 Million EUR | 599.63% |
| 2017 Q3 | 16.27 Million EUR | 1239.92% |
| 2016 Q1 | -4.78 Million EUR | -485.19% |
| 2016 Q4 | 270 Thousand EUR | 125.35% |
| 2016 Q3 | -1.06 Million EUR | -129.33% |
| 2016 FY | 270 Thousand EUR | 133.05% |
| 2016 Q2 | 3.63 Million EUR | 175.95% |
| 2015 Q4 | -817 Thousand EUR | -123.72% |
| 2015 FY | -817 Thousand EUR | -132.37% |
| 2015 Q2 | 6.12 Million EUR | 74.11% |
| 2015 Q1 | 3.51 Million EUR | 39.26% |
| 2015 Q3 | 3.44 Million EUR | -43.71% |
| 2014 FY | 2.52 Million EUR | -68.55% |
| 2014 Q4 | 2.52 Million EUR | 38.0% |
| 2014 Q2 | 1.37 Million EUR | -78.14% |
| 2014 Q1 | 6.28 Million EUR | -21.74% |
| 2014 Q3 | 1.82 Million EUR | 33.21% |
| 2013 Q3 | 10.93 Million EUR | -25.1% |
| 2013 Q4 | 8.02 Million EUR | -26.61% |
| 2013 FY | 8.02 Million EUR | -62.47% |
| 2013 Q1 | 10.41 Million EUR | -51.31% |
| 2013 Q2 | 14.59 Million EUR | 40.21% |
| 2012 FY | 21.38 Million EUR | 111.62% |
| 2012 Q4 | 21.38 Million EUR | 111.57% |
| 2012 Q1 | -176.67 Million EUR | 3.95% |
| 2012 Q2 | -165.46 Million EUR | 6.35% |
| 2012 Q3 | -184.79 Million EUR | -11.68% |
| 2011 Q1 | -300.07 Million EUR | -1.61% |
| 2011 Q4 | -183.94 Million EUR | -23.5% |
| 2011 FY | -183.94 Million EUR | 37.71% |
| 2011 Q3 | -148.94 Million EUR | 24.18% |
| 2011 Q2 | -196.43 Million EUR | 34.54% |
| 2010 Q4 | -295.32 Million EUR | -54.62% |
| 2010 FY | -295.32 Million EUR | -62.48% |
| 2010 Q3 | -190.99 Million EUR | -4.63% |
| 2010 Q2 | -182.53 Million EUR | 1.1% |
| 2010 Q1 | -184.55 Million EUR | -1.54% |
| 2009 Q4 | -181.76 Million EUR | 0.0% |
| 2009 FY | -181.76 Million EUR | -3.35% |
| 2008 FY | -175.87 Million EUR | -1.42% |
| 2007 FY | -173.4 Million EUR | -5917.07% |
| 2006 FY | 2.98 Million EUR | 105.96% |
| 2005 FY | -50 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -30151.381% |
| Ansell Limited | -54.99 Million USD | 363.824% |
| Ansell Limited | -55.1 Million USD | 363.33% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 497.595% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 138151.607% |
| Psykey, Inc. | 634.59 Thousand USD | -22764.261% |
| ConvaTec Group Plc | 1.2 Billion USD | 87.915% |
| ConvaTec Group Plc | 1.2 Billion USD | 87.932% |
| Encision Inc. | 1.29 Million USD | -11141.635% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -6184.659% |
| Innovative MedTech Inc. | 1.76 Million USD | -8121.91% |
| LifePoint, Inc. | -3.26 Million USD | 4545.284% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -2858.597% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -6611.147% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 335161.426% |
| Reflect Scientific, Inc. | -1.03 Million USD | 14114.684% |
| SmileDirectClub, Inc. | 778.67 Million USD | 81.366% |
| Sector 10, Inc. | 163 Thousand USD | -88915.337% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 134.749% |
| SheerVision, Inc. | 57.34 Thousand USD | -252903.54% |
| United Health Products, Inc. | 660.56 Thousand USD | -21865.154% |
| Vasamed, Inc. | 22.12 Thousand USD | -655785.544% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | -5414.364% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -18687.899% |